Cardiol Therapeutics Receives Orphan Drug Designation From FDA for Lead Drug Candidate to Treat Pericarditis

-- Cardiol Therapeutics Inc. on Thursday surged over 26% on last look after reporting that it has secured the Orphan Drug Designation from the US Food and Drug Administration for CardiolRx, the...

Related Keywords

United States , , Drug Administration , Cardiol Therapeutics Inc , Cardiol Therapeutics , Investigational New Drug Application , United States Food , Markets ,